Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
E
E
Zucca
C
C
Copie-Bergman
U
U
Ricardi
C
C
Thieblemont
M
M
Raderer
M
M
Ladetto
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy; D016480:Helicobacter pylori / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D008221:Lymphoid Tissue / Q000473:pathology; D018442:Lymphoma, B-Cell, Marginal Zone / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009367:Neoplasm Staging; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents